Protein levels could predict if bowel cancer patients will benefit from Avastin
Comparing levels of specific proteins that the drug Avastin targets could identify patients with advanced bowel cancer who will benefit from the treatment, according to research published in Clinical Cancer Research.
Cancer
Oct 23, 2012 |
not rated yet |
0
Clinical trials: Around half of new treatments perform better than existing treatments
On average, new treatments perform better in clinical trials only slightly more often than existing treatments, according to a new systematic review published in The Cochrane Library. The fact that experimental treatments are no ...
Medical research
Oct 16, 2012 |
not rated yet |
0
Patient-reported outcomes essential to comparative effectiveness research
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Cancer
Oct 16, 2012 |
not rated yet |
0
New animal models can revolutionize the study of cancer
Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug ...
Cancer
Oct 09, 2012 |
not rated yet |
0
School hearing tests: Are they as good as they sound?
Should every primary school pupil in the UK be given a hearing test and what's the most effective way of doing it? These are questions that a team of academics from Nottingham and Exeter will be tackling as part of a new ...
Health
Oct 09, 2012 |
not rated yet |
0
Scientists identify genetic signatures for aggressive form of prostate cancer
Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease ...
Cancer
Oct 08, 2012 |
5 / 5 (1) |
0
|
Novel blood-based protein signature determined for rare, aggressive lung cancer
Researchers have discovered a panel of 13 blood proteins that may be effective biomarkers to detect malignant mesothelioma, according to a study published Oct. 3 in the open access journal PLOS ONE by Rachel Ostroff from t ...
Cancer
Oct 03, 2012 |
not rated yet |
0
Study finds faults in proposed mental disorder diagnosis
A much anticipated addition to the revised Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5) is questionable according to research findings. The newly revised DSM-5, the first alterations since it ...
Psychology & Psychiatry
Oct 03, 2012 |
4 / 5 (1) |
0
Children underrepresented in drug studies, researchers say
The number of clinical trials enrolling children is far lower than for adults, and the scope of research is also narrower, according to an analysis of public-access data conducted by researchers at Duke University.
Pediatrics
Oct 01, 2012 |
not rated yet |
0
Are too few women being offered breast-conserving treatment?
Two new studies presented at the ESMO 2012 Congress in Vienna, Austria show how improvements in breast cancer treatments are making it possible for more women to conserve their breasts following therapy, but raise concerns ...
Cancer
Sep 30, 2012 |
not rated yet |
0
NIH launches trial for rare degenerative muscle disease treatment
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists ...
Medical research
Sep 24, 2012 |
not rated yet |
0
Model confirms active surveillance as viable option for men with low-risk prostate cancer
A new research model has estimated that the difference in prostate cancer mortality among men with low-risk disease who choose active surveillance versus those who choose immediate treatment with radical prostatectomy is ...
Cancer
Sep 24, 2012 |
not rated yet |
0
|
Denosumab reduces burden of giant-cell tumor of the bone
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...
Cancer
Sep 21, 2012 |
not rated yet |
0
10 drugmakers team up to improve testing process
(AP)—Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.
Medications
Sep 19, 2012 |
not rated yet |
0
Making vaccines more effective
(Medical Xpress)—Scientists have discovered an important mechanism in which a synthetic DNA targets the immune system that could significantly improve the effectiveness of future vaccines.
Immunology
Sep 19, 2012 |
5 / 5 (1) |
0
